Varanasi: In a major breakthrough in the global fight against the SARS-CoV-2 virus, a team of researchers from the Centre for Genetic Disorders at Ban.
News Medical on MSN9h
Human challenge study reveals lasting cognitive decline after mild COVID-19Researchers from the UK conducted the first human challenge study of SARS-CoV-2, revealing long-lasting cognitive deficits in ...
RESEARCH COULD PAVE THE WAY FOR FUTURE COVID-19 TREATMENTS GROUNDBREAKING INNOVATION WITH REGARD TO AYURVEDA IN FIGHT AGAINST COVID-19Varanasi : In a significant breakthrough against the SARS-CoV-2 ...
Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) (‘SBMI’ or ‘the Company’) is pleased to announce it has entered into an ...
When it comes to where the new variant has been detected, right now, it’s more common in Europe. Currently, it’s been ...
When it comes to where the new variant has been detected, right now, it’s more common in Europe. Currently, it’s been ...
The TAGS technology – or Temperature-Activated Generation of Signal to give it its full name – allows up to 15 diagnostic ...
The TAGS technology has PCR testing capabilities on high-throughput systems such as the cobas 5800, 6800, and 8800 models.
Those in the study who had been infected with the virus showed an increase in a brain protein that is often associated with a brain injury.
Basel: Roche announced today the launch of the cobas Respiratory flex test, the first to use Roche's novel and proprietary ...
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a ...
Currently, oseltamivir exists and is available. Although the exact contents of the U.S. Strategic National Stockpile are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback